SHELLI-MARIE NELSON: Open Payments
NPI 1093040354 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 15 payments from 9 companies in 2025. Trend: 2023 $249 · 2024 $388 · 2025 $325
Food & beverage: $304Consulting: $21
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| ADMA BioManufacturing LLC | 1 | $21 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: TRELEGY ELLIPTA, NUCALA, EOHILIA, EBGLYSS, NEFFY, Sajazir, EUCRISA, AIRSUPRA.
Industry payments across NV — which companies pay providers there.
